Related Experiment Video
Updated: Jun 27, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
SOCS1 insufficiency in systemic lupus erythematosus in a child: a case report
Lu Cao1, Qin Wang1, Huating Zhang1
1Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Insights
A child with Systemic Lupus Erythematosus (SLE) had a frameshift variant in the SOCS1 gene. This genetic finding offers new therapeutic targets and biomarkers for SLE treatment.
Area of Science:
- Genetics
- Immunology
- Pediatrics
Background:
- Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease.
- Genetic factors play a significant role in SLE pathogenesis.
- The SOCS1 gene is a potential candidate in autoimmune disorders.
Observation:
- A 6-year-old girl presented with typical SLE symptoms including fever and rash.
- The patient displayed laboratory evidence of lupus, such as hypocomplementemia and autoantibodies.
- A heterozygous frameshift variant in the SOCS1 gene was identified in the patient and her mother.
Findings:
- The identified SOCS1 variant was associated with the patient's SLE diagnosis.
- Treatment with standard immunosuppressants and hydroxychloroquine resulted in clinical improvement.
- This case highlights a potential genetic link between SOCS1 mutations and SLE.
Implications:
- Identifying pathogenic genes like SOCS1 can lead to novel therapeutic strategies for SLE.
- SOCS1 variants may serve as biomarkers for disease diagnosis or prognosis.
- JAK inhibitors show promise for treating SOCS1-related autoimmune conditions.
Abstract:
This case report details a 6-year-old Han Chinese girl diagnosed with Systemic Lupus Erythematosus (SLE) associated with a frameshift variant in the SOCS1 gene. Initially presenting with fever and rash, the patient exhibited abnormal liver function, hypocomplementemia, and positive antinuclear and anti-dsDNA antibodies. Genetic testing identified a heterozygous frameshift mutation in the SOCS1 gene, inherited from her mother. The girl was treated with intravenous methylprednisolone, oral prednisolone, hydroxychloroquine, and mycophenolate mofetil, leading to significant clinical improvement. Considering the clinically relevant variant in SOCS1, the findings suggest that identifying pathogenic genes can facilitate the development of new therapeutic targets and biomarkers, with JAK inhibitors showing promise for treating SOCS1-related conditions.
Related Concept Videos
Pleiotropy
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome I : Introduction
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

